Health, Fitness & Food

It’s Hollywood’s new favorite beauty product. It’s the superfood du jour. Demand for CBD is so strong that companies are scrambling to infuse their products with it, but the CBD they’re finding isn’t all that great. Congress legalized industrial hemp in December. With it, they also legalized hemp-derived CBD, short for cannabidiol, a cannabis compound
0 Comments
Humana executives say they are modeling a number of scenarios to try to figure out how they’ll price their Medicare drug plans for 2020 as the health insurance industry awaits new pharmacy benefit rebate regulations expected this spring from the Trump administration. “We’re spending a lot of time at Humana doing some game theory, a
0 Comments
Sugary drinks may feed colon cancer tumors, according to a study published Thursday in the journal “Science.” High-fructose corn syrup feeds colon tumors in mice, suggesting that drinking soda may produce similar effects in humans, a study from Weill Cornell Medicine, a medical school, and NewYork-Presbyterian Hospital found. Researchers said early stage tumors were eating
0 Comments
CVS Pharmacy said on Wednesday that it has started selling cannabidiol, or CBD, products in select states. The pharmacy chain said the products include topicals such as creams, sprays, roll-ons, lotions and salves. These products are available in 8 states: Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee. In a statement, CVS specified that
0 Comments
People buying medical supplies on Amazon, such as glucometers and cold medicine, can now use their flexible savings accounts or health savings accounts to get discounts. These programs, often referred to as an HSA or FSA, allow people with health insurance to set aside a portion of their salary before taxes to cover medical expenses
0 Comments
Shares of major cannabis companies rallied Tuesday after New Jersey politicians outlined plans to legalize the adult use of recreational marijuana in the state. Several New Jersey legislators joined Democratic Governor Phil Murphy in announcing Tuesday a bill that would allow adult-use marijuana in the Garden State. The legislation would also allow municipalities that are
0 Comments
Some have called Food and Drug Administration Commissioner Scott Gottlieb’s resignation a boon for the e-cigarette industry, which Gottlieb has repeatedly attacked for fueling a surge in teen vaping. The impact of his abrupt resignation, however, may not be that simple. Gottlieb in September declared teen e-cigarette use an “epidemic” and threatened to pull products
0 Comments
The Trump administration is considering a rule that would require hospitals to publicize the prices they negotiate with insurers. The policy is part of a broader proposed rule the Health and Human Services Department is pursing on patient data. The public comment period closes May 3 and the administration could publish a final rule after
0 Comments
Researchers in London are giving hope to finding a cure for AIDS after a second HIV-positive man appears to have shaken the disease following a bone-marrow transplant, according to research published Tuesday by his doctors. Tests confirmed the man’s virus to be undetectable even though he’s been off antiretroviral therapy for 18 months, doctors said
0 Comments
TheFood and Drug Administration called out 15 retailers on Monday for allegedly selling tobacco products to minors and requested information from more than 40 e-cigarette companies the agency thinks may have illegally introduced new products onto the market. The agency named corporate-owned and franchise retailers who were allegedly found selling tobacco products to minors more
0 Comments
Activist investor Starboard Value said Thursday that it intends to use its stake in Bristol-Myers Squibb to oppose the drug-maker’s acquisition of Celgene. “Bristol-Myers is deeply undervalued and the recent announcement of the Company’s proposed acquisition of Celgene Corporation is poorly conceived and ill-advised,” Starboard CEO Jeffrey Smith wrote in a letter to Bristol-Myers shareholders.
0 Comments
Amazon has tapped 14-year company veteran Nader Kabbani to run its new pharmacy business, including the team that came in through last year’s acquisition of PillPack, CNBC has learned. Kabbani, who helped build Amazon’s Kindle self-publishing platform and has served as vice president in the logistics and Flex businesses, is now “vice president of consumables,
0 Comments
Executives from seven drugmakers laid out their ideas for lowering drug prices to the Senate Finance Committee on Tuesday. One idea was noticeably absent: lowering drug prices. The companies — AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi — threw their support behind a number of Trump administration proposals and pitched some
0 Comments
Samsung announced a new line of wearables this week, including a new smartwatch called Galaxy Active. The device claimed to monitor users’ blood pressure, which some suggested would put it ahead of its key rival, Apple, as the first big tech player to make such an important breakthrough. The company said the new feature would
0 Comments